Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Cantor Fitzgerald
Novartis
Deloitte
Harvard Business School
Colorcon
Queensland Health
Fuji
Accenture
Chubb

Generated: October 19, 2017

DrugPatentWatch Database Preview

FELBATOL Drug Profile

« Back to Dashboard

What is the patent landscape for Felbatol, and what generic Felbatol alternatives are available?

Felbatol is a drug marketed by Mylan Speciality Lp and is included in one NDA.

The generic ingredient in FELBATOL is felbamate. There are twelve drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the felbamate profile page.

Summary for Tradename: FELBATOL

US Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list2
Bulk Api Vendors: see list62
Clinical Trials: see list1
Patent Applications: see list2,227
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:FELBATOL at DailyMed

Pharmacology for Tradename: FELBATOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Speciality Lp
FELBATOL
felbamate
SUSPENSION;ORAL020189-003Jul 29, 1993ABRXYesYes► Subscribe► Subscribe► Subscribe
Mylan Speciality Lp
FELBATOL
felbamate
TABLET;ORAL020189-001Jul 29, 1993ABRXYesNo► Subscribe► Subscribe► Subscribe
Mylan Speciality Lp
FELBATOL
felbamate
TABLET;ORAL020189-002Jul 29, 1993ABRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: FELBATOL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan Speciality Lp
FELBATOL
felbamate
TABLET;ORAL020189-002Jul 29, 1993► Subscribe► Subscribe
Mylan Speciality Lp
FELBATOL
felbamate
SUSPENSION;ORAL020189-003Jul 29, 1993► Subscribe► Subscribe
Mylan Speciality Lp
FELBATOL
felbamate
TABLET;ORAL020189-001Jul 29, 1993► Subscribe► Subscribe
Mylan Speciality Lp
FELBATOL
felbamate
TABLET;ORAL020189-001Jul 29, 1993► Subscribe► Subscribe
Mylan Speciality Lp
FELBATOL
felbamate
TABLET;ORAL020189-002Jul 29, 1993► Subscribe► Subscribe
Mylan Speciality Lp
FELBATOL
felbamate
SUSPENSION;ORAL020189-003Jul 29, 1993► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKinsey
Farmers Insurance
Boehringer Ingelheim
Teva
McKesson
Novartis
Colorcon
Citi
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot